Business Lead Pharma & Bio
- Hiring from
- Estonia
- Work type
- Hybrid
- Posted
626,394 remote jobs, straight from company career pages
100% free · New jobs every minute
Show job descriptionHide job description
The University of Tartu sits on one of Europe's few population-scale genomic resources - 212,000 people genotyped with linked clinical and health-record data alongside a drug-delivery and therapeutics portfolio spanning oncology, CNS, metabolic and inflammatory disease. Almost none of it has been tested against pharma demand.
We're now looking for the person who'll change that: a senior individual contributor who brings commercial thinking to the research stage - assessing market potential while assets are still being shaped, using industry as a sounding board rather than an end customer, and finding viable paths early enough to actually influence them.
What you'll own
🕵️ ♀️ Asset validation and deal-making. Working downstream of our innovation scouts who surface assets and early signal from across the university you'll start with structured market discovery, calibrated value propositions, and honest deprioritisation where warranted, then drive the deals that follow: licensing, co-development, spinoff instruments. You own the lifecycle from first qualified contact to close, and a well-argued "don't proceed" is worth as much as a deal that closes.You'll also shape how the scouts work: feeding back what pharma actually asks for, and sharpening which assets are worth surfacing in the first place.
📊 Commercial governance. We run large multi-stakeholder programmes in personalised medicine and genomics where commercial outcomes are structurally intended but practically absent. Assess what's possible within consortium constraints, tell us what needs to change, and own that interface going forward.
🤝 Network and specialist capacity. Build pharma and biotech relationships that run both ways - channelling industry priorities back into our research strategy, routing scientific assets out when the timing is right. You'll work alongside two innovation scouts (Medical Faculty; Institute of Genomics) and a junior BD generalist, doing some of this yourself and orchestrating the rest.
The first 1️⃣2️⃣ months
Months 1-3, context: sitting in on live conversations, meeting PIs in priority areas, reading IP files, identifying the assets worth structured discovery and the obvious governance gaps.
Months 3-6, market discovery: pharma external innovation, biotech CBOs, specialist scouts; refining value propositions; starting the IP capture review.
Months 6-12, operational: first-line relationships with 5–10 strategic international accounts, commercial governance written into our active personalised-medicine consortium, at least two research-collaboration conversations live. We don't expect a closed deal in year one but we do expect the foundation for a year-two close to be visibly built.
Focus areas 🔍
Population genomics and personalised medicine Estonian Biobank, the eQTL Catalogue built with EMBL-EBI, population-scale pharmacogenomics. Peptide and nanoparticle drug delivery - tumour-microenvironment targeting, brain-penetrating sequences, cleavable constructs. Emerging platforms - self-amplifying mRNA, anti-inflammatory nanoparticles, and small molecules across metabolic disease and oncology.
Who you are
You've run a life sciences licensing or partnership deal end-to-end from first contacts to term sheet and close. That might come from pharma external innovation, a senior BD/CBO seat at a platform-stage biotech, a deal-carrying commercialisation role at a research-intensive university, or life sciences BD at a boutique advisory.
This role is not cut for generalist BD without life-science depth, academic project management without a deal record, or pure venture/angel investing without operating BD experience.
You think in deals, not activities. You can tell us which questions an asset needs answered before it's worth taking to market, and, just as important, which to stop asking. You're comfortable telling a star researcher their asset isn't ready, and a pharma scout why ours is. You've built a BD pipeline from a low base, not just optimised someone else's. You're at ease in academic environments without being captured by them and senior enough to push back when something's wrong, including pushing back on me.
📍Practical
Location: Tartu, Estonia but part-time remote with monthly travel is a realistic alternative.
Travel: Up to 25%.
Compensation: base salary plus deal-closure bonus.
Start: ASAP.
Working language English; Estonian is a slight plus.
📝 How to apply
Apply here with CV and a short note describing your role in your most significant deal (within confidentiality limits), including the structure of the agreement, what made it work or nearly fail, and what you'd do differently with hindsight.
For a confidential conversation before applying, email directly to kadri.sundja@ut.ee